Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Mr. David A. RamsayPresident of Drug Delivery | -5,41k | 423,28k | Derivative Exercise and Sale | 78,27 | 4,59k | - |
| 2026-06-30 | Mr. David A. RamsayPresident of Drug Delivery | 4,59k | 0,00 | Derivative Exercise and Retained Stock | - | 4,59k | - |
| 2026-07-01 | Ms. Bernadette Mary ConnaughtonIndependent Director | -1,63k | 124,65k | Automatic Disposition | 76,40 - 77,21 | 35,25k | -4,41% |
| 2026-06-29 | Dr. Mahesh KrishnanIndependent Director | -7,30k | 266,89k | Derivative Exercise and Sale | 38,46 - 75,00 | 10,67k | - |
| 2026-06-12 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | 2,32k | 0,00 | Derivative Exercise and Retained Stock | - | 49,93k | 4,87% |
| 2026-06-12 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | -2,72k | 188,69k | Derivative Exercise and Sale | 69,50 | 49,93k | - |
| 2026-06-01 | Dr. Helen I. TorleyPresident, CEO & Director | -50,00k | 2,77M | Derivative Exercise and Sale | 12,07 - 69,69 | 767,78k | - |
| 2026-06-01 | Ms. Bernadette Mary ConnaughtonIndependent Director | -1,63k | 107,59k | Automatic Disposition | 66,21 | 36,87k | -4,22% |
| 2026-05-11 | Dr. Helen I. TorleyPresident, CEO & Director | -50,00k | 2,83M | Derivative Exercise and Sale | 12,07 - 73,12 | 767,78k | - |
| 2026-05-01 | Ms. Bernadette Mary ConnaughtonIndependent Director | -1,63k | 103,16k | Automatic Disposition | 63,48 | 38,50k | -4,05% |
| 2026-04-06 | Dr. Helen I. TorleyPresident, CEO & Director | -10,00k | 514,28k | Derivative Exercise and Sale | 12,07 - 64,02 | 767,78k | - |
| 2026-04-01 | Dr. Helen I. TorleyPresident, CEO & Director | -40,00k | 2,11M | Derivative Exercise and Sale | 12,07 - 65,71 | 767,78k | - |
| 2026-03-09 | Ms. Cortney CaudillInsider | -21,55k | 738,64k | Derivative Exercise and Sale | 33,51 - 68,25 | 7,06k | - |
| 2026-03-10 | Ms. Cortney CaudillInsider | -7,31k | 494,52k | Verkauf | 67,64 | 7,06k | -50,89% |
| 2026-03-02 | Dr. Helen I. TorleyPresident, CEO & Director | -50,00k | 2,87M | Derivative Exercise and Sale | 12,07 - 70,95 | 767,78k | - |
| 2026-02-20 | Ms. Cortney CaudillInsider | 1,63k | 0,00 | Derivative Exercise and Retained Stock | - | 14,37k | 12,79% |
| 2026-02-20 | Ms. Cortney CaudillInsider | -1,04k | 73,61k | Derivative Exercise and Sale | 70,98 | 14,37k | - |
| 2026-02-20 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | 5,69k | 0,00 | Derivative Exercise and Retained Stock | - | 47,61k | 13,56% |
| 2026-02-20 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | -6,66k | 471,30k | Derivative Exercise and Sale | 70,64 - 70,98 | 47,61k | - |
| 2026-02-20 | Ms. Nicole LaBrosseInsider | 5,54k | 0,00 | Derivative Exercise and Retained Stock | - | 38,49k | 16,80% |
| 2026-02-20 | Ms. Nicole LaBrosseInsider | -6,48k | 459,01k | Derivative Exercise and Sale | 70,64 - 70,98 | 38,49k | - |
| 2026-02-20 | Dr. Helen I. TorleyPresident, CEO & Director | 18,05k | 0,00 | Derivative Exercise and Retained Stock | - | 767,78k | 2,41% |
| 2026-02-20 | Dr. Helen I. TorleyPresident, CEO & Director | -21,14k | 1,50M | Derivative Exercise and Sale | 70,64 - 70,98 | 767,78k | - |
| 2026-02-16 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | 7,74k | 0,00 | Derivative Exercise and Retained Stock | - | 41,93k | 22,66% |
| 2026-02-16 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | -9,07k | 720,36k | Derivative Exercise and Sale | 79,44 | 41,93k | - |
| 2026-02-16 | Ms. Nicole LaBrosseInsider | 10,88k | 0,00 | Derivative Exercise and Retained Stock | - | 32,96k | 49,27% |
| 2026-02-16 | Ms. Nicole LaBrosseInsider | -12,89k | 1,02M | Derivative Exercise and Sale | 79,44 | 32,96k | - |
| 2026-02-16 | Dr. Helen I. TorleyPresident, CEO & Director | 41,01k | 0,00 | Derivative Exercise and Retained Stock | - | 749,73k | 5,79% |
| 2026-02-16 | Dr. Helen I. TorleyPresident, CEO & Director | -48,04k | 3,82M | Derivative Exercise and Sale | 79,44 | 749,73k | - |
| 2026-02-03 | Dr. Helen I. TorleyPresident, CEO & Director | -50,00k | 3,25M | Derivative Exercise and Sale | 12,07 - 78,94 | 708,72k | - |
| 2026-01-05 | Ms. Bernadette Mary ConnaughtonIndependent Director | -2,00k | 140,50k | Automatic Disposition | 70,25 | 35,96k | -5,27% |
| 2026-01-03 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | 3,37k | 0,00 | Derivative Exercise and Retained Stock | - | 34,18k | 10,93% |
| 2026-01-03 | Mr. Mark SnyderSenior VP, General Counsel, CCO & Corporate Secretary | -4,24k | 298,33k | Derivative Exercise and Sale | 70,31 | 34,18k | - |
| 2025-11-01 | Ms. Cortney CaudillInsider | 5,06k | 0,00 | Derivative Exercise and Retained Stock | - | 12,74k | 65,98% |
| 2025-11-01 | Ms. Cortney CaudillInsider | -4,26k | 277,90k | Derivative Exercise and Sale | 65,19 | 12,74k | - |
| 2025-12-01 | Ms. Bernadette Mary ConnaughtonIndependent Director | -829,00 | 59,36k | Automatic Disposition | 71,60 | 37,96k | -2,14% |
| 2025-12-01 | Dr. Helen I. TorleyPresident, CEO & Director | -16,57k | 1,01M | Derivative Exercise and Sale | 8,11 - 71,60 | 708,72k | - |
| 2025-11-26 | Dr. Helen I. TorleyPresident, CEO & Director | -25,00k | 0,00 | Other Disposition | - | 708,72k | -3,41% |
| 2025-11-10 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 3,68M | Derivative Exercise and Sale | 8,11 - 71,67 | 733,72k | - |
| 2025-11-10 | Ms. Bernadette Mary ConnaughtonIndependent Director | -2,00k | 136,96k | Automatic Disposition | 68,48 | 38,79k | -4,90% |
| 2025-10-01 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 3,83M | Derivative Exercise and Sale | 8,11 - 75,69 | 733,72k | - |
| 2025-10-01 | Ms. Bernadette Mary ConnaughtonIndependent Director | -2,00k | 150,48k | Automatic Disposition | 75,09 - 75,70 | 40,79k | -4,67% |
| 2025-09-22 | Ms. Nicole LaBrosseInsider | -2,23k | 173,58k | Automatic Disposition | 77,83 - 78,67 | 22,08k | -9,16% |
| 2025-09-10 | Ms. Nicole LaBrosseInsider | -12,41k | 787,45k | Derivative Exercise and Sale | 12,07 - 75,93 | 24,31k | - |
| 2025-09-10 | Ms. Nicole LaBrosseInsider | -7,59k | 576,60k | Automatic Disposition | 75,93 | 24,31k | -23,81% |
| 2025-09-02 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 3,96M | Derivative Exercise and Sale | 8,11 - 75,22 | 733,72k | - |
| 2025-09-02 | Ms. Bernadette Mary ConnaughtonIndependent Director | -4,00k | 294,74k | Automatic Disposition | 71,71 - 74,11 | 42,79k | -8,55% |
| 2025-08-11 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 3,33M | Derivative Exercise and Sale | 8,11 - 64,83 | 733,72k | - |
| 2025-07-08 | Dr. Helen I. TorleyPresident, CEO & Director | -60,00k | 2,90M | Derivative Exercise and Sale | 8,11 - 57,62 | 733,72k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
